SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Sundry Debtors History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2017 | Mar2016 | |
---|---|---|---|---|---|
Sundry Debtors | ₹103 Cr | ₹76 Cr | ₹68 Cr | ₹46 Cr | ₹46 Cr |
What is the latest Sundry Debtors ratio of SYNCOM FORMULATIONS (INDIA) ?
Year | Sundry Debtors |
---|---|
Mar2024 | ₹103 Cr |
Mar2023 | ₹76 Cr |
Mar2022 | ₹68 Cr |
Mar2017 | ₹46 Cr |
Mar2016 | ₹46 Cr |
How is Sundry Debtors of SYNCOM FORMULATIONS (INDIA) Trending?
Years | Sundry Debtors | % Change | |
---|---|---|---|
Mar2024 | ₹103 Cr | 36.81 | |
Mar2023 | ₹76 Cr | 11.78 | |
Mar2022 | ₹68 Cr | 46.86 | |
Mar2017 | ₹46 Cr | 0.00 | |
Mar2016 | ₹46 Cr | - |
Compare Sundry Debtors of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹1,817.0 Cr | -11.5% | -2.2% | 59.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹395,326.0 Cr | -2.3% | -3.5% | 9.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,562.0 Cr | -2.8% | 1.3% | 42.3% | Stock Analytics | |
CIPLA | ₹121,023.0 Cr | -0.3% | 3% | -2.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,558.0 Cr | -3.7% | 7.2% | 8.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,204.0 Cr | -1% | -0.5% | 13.2% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | -11.5% |
-2.2% |
59.4% |
SENSEX | -1.3% |
-0.8% |
6.3% |
You may also like the below Video Courses